Navigation Links
China Biologic Products Hosts its First Forum for Strategy and Development
Date:7/16/2009

TAIAN CITY, China, July 16 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company hosted a forum of industry experts on July 10 - 11, 2009, at its headquarters in Tai'an, Shandong Province, to discuss future development strategies for the Company.

Experts from the bio-pharmaceutical industry included Mr. Zhongwei Zheng, head of the research and development center at the Institute of Blood Transfusion at the Chinese Academy of Medical Science, and Mr. Fengshan Wang, Dean of School of Pharmaceutical Sciences at the Shandong University. Messrs. Zheng and Wang and other domestic and international academics and experts, gathered together to discuss strategies for the development of the new China Biologic, which recently became the largest non-state-owned plasma-based pharmaceutical Company in China following the Company's acquisitions of Dalin Biologic Technologies and also its equity investment in Xi'an Huitian Blood Products.

The forum provided a platform for industry experts to discuss and provide advice to the Company that could create synergies among its subsidiaries including, the initiation of research and development of new drugs, efficient use of resources among the subsidiaries, quality control procedures during collection, production and distribution processes, and other expert opinions to create long term, sustainable growth for the Company.

"The forum has provided us with many strategic ideas to further the growth of the new China Biologic," said Mr. Chao Ming Zhao, CEO of China Biologic Products. "We look forward to implementing some of those strategies and create synergies among our subsidiaries."

About China Biologic Products, Inc.

China Biologic Produ
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China
2. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
3. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results
4. China Clean Energy Provides Business Update
5. China Kangtai Cactus Biotech Retains Hawk Associates for Investor Relations Services
6. RainEarth (RNER) Continues to Expand its Marketing Force in China
7. Sinovac Receives Chinas First Influenza A (H1N1) Vaccine Order
8. China-Biotics, Inc. to Join Russell 3000 Index
9. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
10. China Biologic Products Closes the $9.6 Million Private Placement
11. China Biologic Products Enters Into Private Placement Agreements to Raise $9.6 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report ... of sequencing technologies, and their applications. Current large ... companies developing them. Various applications of sequencing are ...
(Date:9/2/2015)... , Sep. 02, 2015 ... http://www.researchandmarkets.com/research/bvxxkf/cytogenetics ) has announced the addition of ... Technologies, Markets and Companies" to their ... includes several technologies besides fluorescence in situ ... multicolor FISH. Molecular cytogenetics includes application of ...
(Date:9/2/2015)... , Sept. 2, 2015 Aytu BioScience, ... developing treatments for urological and related conditions, announced today ... planned private placement convertible note financing, raising a total ... tranches totaling $3.175 million. Josh ... from this private placement are intended to be used ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... critical demand to aid high-risk surgeries. From vital sign monitoring in ICU to ... Intel technology enables surgeon to make real-time clinical decisions with simultaneous access to ...
Breaking Biology Technology:Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3
... clinical trials of its treatment for ... inflammatory bowel disease., OKLAHOMA CITY, ... capital financing to fund clinical trials,testing the efficacy of its therapy ... the round and was joined by the,Oklahoma Seed Capital Fund and ...
... Sept. 18 The future of health care ... into practice and,health policy. But putting research into ... the pace of cutting-edge care. Kaiser,Permanente Colorado is ... at getting research into practice and policy more,quickly ...
... (Nasdaq: ONXX ) today announced that it ... on Monday, September 24, at 9:00,a.m. Eastern Time. ... the,presentation at: http://events.streamx.us/us/event/eventdetails.aspx?id=ubs20070924 It ... early in order to,register and download any necessary ...
Cached Biology Technology:Altheus Therapeutics Secures $3.6 Million in Venture Capital 2Kaiser Permanente Colorado Opens Center for Health Dissemination and Implementation Research 2
(Date:7/31/2015)... Den 10. internationale konference om Genomik (ICG-10, ... - 25. oktober i Shenzhen , ... i år. Siden starten i 2006 er ICB blevet ... og er en af de mest dynamiske, entusiastiske og ... nylige gennembrud og fremskridt inden for ,omik,-forskning, som yderligere ...
(Date:7/31/2015)... 2015 A 10 a. Conferência Internacional ... BGI de 22-25 de outubro de 2015, em ... está celebrando seu 10 o. aniversário este ano. Desde ... das reuniões mais influentes do mundo no ramo das ... e prazerosos. A ICG-10 se concentra ...
(Date:7/31/2015)... de 2015 La 10 th International Conference ... de BGI del 22 al 25 de octubre de 2015 en ... año, la conferencia celebra su décimo aniversario. Desde su inauguración ... de las reuniones anuales más influyentes del mundo en el ... dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... a sun-powered adventure this autumn when the Durham University Solar ... Using nothing but solar power, the DUSC team will travel ... to Adelaide in the south. The Durham car is ... after taking part in endurance testing in the UK. The ...
... major Center that will propel scientific efforts to pinpoint the ... diseases will be opened today at the La Jolla Institute ... known as RNA interference (RNAi), the Institute,s new RNAi Center ... against myriad diseases, and is one of a small, select ...
... not a single process but is made up of several ... the ability to remember specific events such as what you ... involving the hippocampus. The question is, what happens when damage ... case study published in the September 2011 issue of Elsevier,s ...
Cached Biology News:Durham University solar car takes on World Solar Challenge 2La Jolla Institute opens major RNAi center for identifying genetic triggers of disease 2La Jolla Institute opens major RNAi center for identifying genetic triggers of disease 3La Jolla Institute opens major RNAi center for identifying genetic triggers of disease 4When you can recite a poem but not remember who asked you to learn it a few days earlier 2
Ultra Pure Grade. Used in conjunction with IPTG to identify bacterial colonies that contain recombinant plasmids by blue/white selection. X-Gal forms an intense blue precipitate in the presence of be...
5-bromouridine 5'-triphosphate (BrUTP) *10 mM in TE buffer*...
...
in vitro Translation, Accessory Products...
Biology Products: